Article | March 9, 2021

High-Quality Chromatography System Meets Predesigned DeltaV For Integrated Manufacturing

Source: Cytiva

By Torbjörn Blank, Product Manager, and Mikael Björling, Automation Engineer, Cytiva


Automation will drive optimization and connectedness throughout development and manufacturing, playing an essential role in the future of biopharma. Future-proofing your facility by implementing automated technologies that enable scale-up can enhance consistency and reliability and improve the quality of your drug product.

However, there is a growing trend with drug manufacturers implementing full-scale automation to leave critical decisions about the system's and facility's key functionality to the engineering company configuring the distributed control system (DCS). Without bioprocessing knowledge, a third-party integrator could create a system that won't work in the best way.

Cytiva has developed ÄKTA process DCS, a turnkey solution that combines proven industrial automation with a high-quality chromatography system. The system comes with a predefined automation software solution that applies Cytiva’s process and equipment expertise to Emerson’s DeltaV™ DCS platform.

With the ÄKTA process DCS, Cytiva’s automation experts collaborate with in-house application and process specialists to ensure they understand your needs and build a system with the critical functionality needed for every step in your process.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online